ResearcherChulalongkorn UniversityActive in the last 2 years
Nipan Israsena
Matched on ORCID iD 0000-0003-1954-6567; OpenAlex author ID A5004925336. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2024: 1 paper · 2025: 2 papers
Papers 3
- Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2535-7440↗
- Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ductal adenocarcinoma. Co-author DOI 10.1055/a-2571-2951↗
- A prospective comparative trial to determine the optimal number of EUS-guided fineneedle passes for successful organoid creation in pancreatic ductal adenocarc… Last author DOI 10.1097/eus.0000000000000098↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Pradermchai Kongkam · 3 shared papers, 2024–2025 · strength 0.70
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper A prospective comparative trial to determine the optimal number of EUS-guided fineneedle passes for successful organoid… DOI 10.1097/eus.0000000000000098↗
- Rungsun Rerknimitr · 3 shared papers, 2024–2025 · strength 0.70
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Paper A prospective comparative trial to determine the optimal number of EUS-guided fineneedle passes for successful organoid… DOI 10.1097/eus.0000000000000098↗
- Phonthep Angsuwatcharakon · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Thaninee Prasoppokakorn · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Parit Mekaroonkamol · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Roongruedee Chaiteerakij · 2 shared papers, 2025 · strength 0.49
- Paper Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III pancreatic ducta… DOI 10.1055/a-2535-7440↗
- Paper Correction: Portal versus peripheral circulating tumor cells as prognostic biomarkers in patients with stage I-III panc… DOI 10.1055/a-2571-2951↗
- Thanawat Luangsukrerk · 1 shared paper, 2024 · strength 0.21
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.